[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352977-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352977-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","s1p-in-tumor-microenvironment-and-modulation-of-anti-tumor-directed-t-cell-responses","S1P in Tumor Microenvironment and Modulation of Anti-Tumor-Directed T-Cell Responses","","Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TILs) has produced clinically and biologically meaningful responses in patients with solid tumors. Increasing efficacy correlates with specific T-cell phenotypes, especially CD8+ TILs with a progenitor stem-cell-like profile (CD39− CD69−). This review explains how the sphingosine-1-phosphate (S1P) axis coordinates these responses, including antagonism between CD69 and S1PR1, thymic selection outcomes, tissue retention versus recirculation, mitochondrial fitness, and the dual role of S1P in tumor microenvironments. It also summarizes clinical trials targeting S1P signaling or production, as of January 2026.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/s1p-in-tumor-microenvironment-and-modulation-of-anti-tumor-directed-t-cell-responses/352977/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/s1p-in-tumor-microenvironment-and-modulation-of-anti-tumor-directed-t-cell-responses/352977.png","ImageObject",300,407,{"name":42,"@type":43},"Pentious","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is the S1P axis important for anti-tumor T-cell responses in solid cancer?","Question",{"text":63,"@type":64},"The review highlights that S1P signaling coordinates T-cell retention or recirculation, long-term immune surveillance, and regulation of mitochondrial fitness, which supports the high energetic demands of precursor T-cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do CD69 and S1PR1 interact to influence thymic selection and tissue behavior?",{"text":68,"@type":64},"The document describes a biological antagonism between the activation marker CD69 and S1P receptor 1 (S1PR1), where mutual exclusivity helps determine whether T-cells are retained in tissues or allowed to recirculate.",{"name":70,"@type":61,"acceptedAnswer":71},"What are the “double-edged sword” effects of S1P in the tumor microenvironment?",{"text":72,"@type":64},"S1P can promote pro-tumorigenic processes such as angiogenesis and vascular mimicry, be hijacked by cancer cells to create immune-excluded environments, or alternatively increase T-cell fitness to support anti-tumor immunity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352977,1790629722,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review  \nS1P in Tumor Microenvironment and Modulation of Anti-Tumor-Directed T-Cell Responses  \nPatrícia A. António 1, Joana R. Lérias 1, Carolina M. Gorgulho 1, Karina Balan 1, Vitaly Balan 1 and Markus J. Maeurer 1,2, *  \n1 Immunotherapy/ImmunoSurgery Laboratory, Cell Center at the Champalimaud Foundation, Avenida Brasília, 1400-038 Lisbon, Portugal; [patricia.antonio@research.fchampalimaud.org](patricia.antonio@research.fchampalimaud.org) (P.A.A.);  \n[joana.lerias@research.fchampalimaud.org](joana.lerias@research.fchampalimaud.org) (J.R.L.); carolina.gorgulho@research.fchampalimaud.org (C.M.G.);  \n[karina.balan@research.fchampalimaud.org](karina.balan@research.fchampalimaud.org) (K.B.); [vitaly.balan@research.fchampalimaud.org](vitaly.balan@research.fchampalimaud.org) (V.B.)  \n2 I Med Clinic, Johannes Gutenberg University of Mainz, 55131 Mainz, Germany  \n* [Correspondence: markus.maeurer@fundacaochampalimaud.pt](Correspondence: markus.maeurer@fundacaochampalimaud.pt)  \nAbstract  \nAdoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TILs) has achieved clinically and biologically relevant responses in patients with solid cancer. Clinical efficacy has been increasingly linked to a specific T-cell phenotype, particularly CD8+ TILs exhibiting a progenitor stem-cell-like profile (CD39 − CD69 − ) . This review explores the critical role of the sphingosine-1-phosphate (S1P) axis in orchestrating these responses. We detail the biological antagonism between the activation marker CD69 and S1P receptor 1 (S1PR1), where mutual exclusivity dictates thymic selection, if T-cells are retained in tissues or allowed to recirculate and maintain long-term immune surveillance. The S1PR1:S1P axis is further recognized as a critical regulator of mitochondrial fitness, sustaining the high energetic demands of precursor T-cells. We examine the “double-edged sword” nature of S1P in the tumor microenvironment (TME), where it can drive pro-tumorigenic processes like angiogenesis and vascular mimicry (VM), be hijacked by cancer cells to create immune-excluded environments, or S1P can increase T-cell fitness. We summarize the current landscape of clinical trials (as of January 2026) that target S1P production or signaling to modulate anti-tumor responses or use S1P as a biologically relevant marker of treatment outcome.  \nKeywords: tumor-infiltrating lymphocytes; S1P; sphingosine-1-phosphate receptor; T-cell receptor; CD69  \nAcademic Editors: Fábio Rinaldo Santori and Natalia  \nB. Ivanova  \nReceived: 2 January 2026  \nRevised: 12 May 2026  \nAccepted: 13 May 2026  \nPublished: 15 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1. Introduction  \nAdoptive cell therapy (ACT) has achieved clinically and biologically relevant responses in patients with solid cancer, and 2024 witnessed the first FDA approval of tumorinfiltrating lymphocytes (TILs) for patients with metastatic melanoma [1] . Phenotypic flow cytometric analyses are used to assess the release of TIL products prior to therapy. These include IFN-γ production in response to T-cell receptor (TCR) cross-linking [2–6] as well as exploratory assays to map the immune reactivity of TIL [7,8] to private mutations, which have been described as targets for clinically relevant immune responses in patients with solid cancer. This was first described by Wolfel and coworkers for T-cells from a patient with melanoma targeting a CDK4 point mutation [9] . Other tumor antigens associated with clinically relevant responses have also been described—non-mutant tumor-associated antigens, such as Melan-A/MART-1, gp100, or tyrosinase—for patients with melanoma [10];  \ncancer–testis antigens, such as NY-ESO-1 [11]; or antigens expressed at low levels in healthy tissue, yet overexpressed in cancer, such as mesothelin [12] or PRAME [13] . The latter","cbCailJcaRWhy9o2","https://ap.wps.com/l/cbCailJcaRWhy9o2","pdf",1808064,24,"English","# Introduction\n## Adoptive cell therapy and clinically relevant tumor antigens\n## Assessing TIL release and T-cell activation\n## Phenotype–function links and clinical relevance\n# S1P axis in T-cell modulation\n## CD69–S1PR1 antagonism and tissue recirculation\n## Mitochondrial fitness and precursor T-cell energetics\n## Double-edged S1P effects in the tumor microenvironment\n# Clinical trials targeting S1P signaling (as of January 2026)","[{\"question\":\"Why is the S1P axis important for anti-tumor T-cell responses in solid cancer?\",\"answer\":\"The review highlights that S1P signaling coordinates T-cell retention or recirculation, long-term immune surveillance, and regulation of mitochondrial fitness, which supports the high energetic demands of precursor T-cells.\"},{\"question\":\"How do CD69 and S1PR1 interact to influence thymic selection and tissue behavior?\",\"answer\":\"The document describes a biological antagonism between the activation marker CD69 and S1P receptor 1 (S1PR1), where mutual exclusivity helps determine whether T-cells are retained in tissues or allowed to recirculate.\"},{\"question\":\"What are the “double-edged sword” effects of S1P in the tumor microenvironment?\",\"answer\":\"S1P can promote pro-tumorigenic processes such as angiogenesis and vascular mimicry, be hijacked by cancer cells to create immune-excluded environments, or alternatively increase T-cell fitness to support anti-tumor immunity.\"}]","S1P in Tumor Microenvironment and Modulation of Anti-Tumor-Directed T-Cell Responses | PDF",1790102369,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d3b3e1c00766cb33c93fcea1a5d62ad.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/720b6e7a2170296c0dc5adc3c76f5497.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/120f9a6f55647aadaff99bdccf3fb28a.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68a89e690310d5b6418fa651bfcfeec4.webp",980,1385]